SōKO Molly 2.0 – Gel Capsules

SōKO describes Molly 2.0 Gel Caps as two vegan soft-gel capsules per pack, with 100 mg of 5-MAPB per capsule and 200 mg total per pack. The page describes the capsules as slow-release, intended to produce a more gradual onset. That delivery description is SōKO’s claim.

SōKO lists possible effects involving mood, emotional openness, empathy, sociability, and sensory awareness. Individual responses can vary. The page includes serving recommendations, which I haven’t repeated here.

A few product notes: SōKO says the product is for adults 21 and older. Its page advises against driving or operating machinery after use and combining it with SSRIs, MAOIs, SAMe, or other serotonin-affecting substances. It also says to consult a physician if taking prescription medication, and warns against use by people who are pregnant, nursing, prone to seizures, or have cardiovascular conditions. Keep away from children and pets.

Lab information: SōKO links a certificate for a 5-MAPB isolate sample, not the finished gel caps. The certificate reports 94.792% 5-MAPB in that sample; it lists metals, pesticides, residual solvents, and microbial testing as not tested.

FDA disclaimer: SōKO says the product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

Legal statement: SōKO states that 5-MAPB is not federally scheduled. That is the manufacturer’s statement, not an independent legal determination.